{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:05:23Z","timestamp":1794265523427,"version":"4.9.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Juseliuksen Saatio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.msard.2021.102810","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T12:48:55Z","timestamp":1612270135000},"page":"102810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis"],"prefix":"10.1016","volume":"50","author":[{"given":"Maija","family":"Saraste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Bezukladova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5597-2670","authenticated-orcid":false,"given":"Markus","family":"Matilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Sucksdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.102810_bib0001","doi-asserted-by":"crossref","unstructured":"Abdelhak, A., A. Huss, J. Kassubek, H. Tumani, and M. Otto, 2018, Serum GFAP as a biomarker for disease severity in multiple sclerosis: Sci Rep, vol. 8, p. 14798.","DOI":"10.1038\/s41598-018-33158-8"},{"key":"10.1016\/j.msard.2021.102810_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/ane.12797","article-title":"Diffusion tensor imaging in multiple sclerosis at different final outcomes","volume":"137","author":"Andersen","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.msard.2021.102810_bib0003","doi-asserted-by":"crossref","unstructured":"Ayrignac, X., E. Le Bars, C. Duflos, C. Hirtz, A. Maleska Maceski, C. Carra-Dalli\u00e8re, M. Charif, F. Pinna, P. Prin, N. Menjot de Champfleur, J. Deverdun, T. Kober, B. Marechal, M. J. Fartaria, R. Corredor Jerez, P. Labauge, and S. Lehmann, 2020, Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity: Sci Rep, vol. 10, p. 10923.","DOI":"10.1038\/s41598-020-67934-2"},{"key":"10.1016\/j.msard.2021.102810_bib0004","doi-asserted-by":"crossref","unstructured":"Barro, C., P. Benkert, G. Disanto, C. Tsagkas, M. Amann, Y. Naegelin, D. Leppert, C. Gobbi, C. Granziera, \u00d6. Yaldizli, Z. Michalak, J. Wuerfel, L. Kappos, K. Parmar, and J. Kuhle, 2018, Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis: Brain, vol. 141, p. 2382-2391.","DOI":"10.1093\/brain\/awy154"},{"key":"10.1016\/j.msard.2021.102810_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000691","article-title":"Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging","volume":"7","author":"Bezukladova","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.msard.2021.102810_bib0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/ane.12239","article-title":"Assessing tissue damage in multiple sclerosis: a biomarker approach","volume":"130","author":"Burman","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.msard.2021.102810_bib0007","doi-asserted-by":"crossref","unstructured":"Cant\u00f3, E., C. Barro, C. Zhao, S. J. Caillier, Z. Michalak, R. Bove, D. Tomic, A. Santaniello, D. A. H\u00e4ring, J. Hollenbach, R. G. Henry, B. A. C. Cree, L. Kappos, D. Leppert, S. L. Hauser, P. Benkert, J. R. Oksenberg, and J. Kuhle, 2019, Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years: JAMA Neurol.","DOI":"10.1001\/jamaneurol.2019.2137"},{"key":"10.1016\/j.msard.2021.102810_bib0008","doi-asserted-by":"crossref","unstructured":"Cardenas, A. M., J. E. Sarlls, J. Y. Kwan, D. Bageac, Z. S. Gala, L. E. Danielian, A. Ray-Chaudhury, H. W. Wang, K. L. Miller, S. Foxley, S. Jbabdi, R. C. Welsh, and M. K. Floeter, 2017, Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study: Neuroimage-Clinical, vol. 15, p. 200-208.","DOI":"10.1016\/j.nicl.2017.04.024"},{"key":"10.1016\/j.msard.2021.102810_bib0009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.msard.2021.102810_bib0011","doi-asserted-by":"crossref","unstructured":"H\u00f6gel, H., E. Rissanen, C. Barro, M. Matilainen, M. Nylund, J. Kuhle, and L. Airas, 2020, Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity: Mult Scler, vol. 26, p. 210-219.","DOI":"10.1177\/1352458518819380"},{"key":"10.1016\/j.msard.2021.102810_bib0012","doi-asserted-by":"crossref","unstructured":"Kuhle, J., H. Kropshofer, D. A. Haering, U. Kundu, R. Meinert, C. Barro, F. Dahlke, D. Tomic, D. Leppert, and L. Kappos, 2019, Blood neurofilament light chain as a biomarker of MS disease activity and treatment response: Neurology, vol. 92, p. e1007-e1015.","DOI":"10.1212\/WNL.0000000000007032"},{"key":"10.1016\/j.msard.2021.102810_bib0013","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez, M. A., B. Olsson, L. Bau, E. Matas, \u00c1. Cobo Calvo, U. Andreasson, K. Blennow, L. Romero-Pinel, S. Mart\u00ednez-Y\u00e9lamos, and H. Zetterberg, 2015, Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis: Mult Scler, vol. 21, p. 550-61.","DOI":"10.1177\/1352458514549397"},{"key":"10.1016\/j.msard.2021.102810_bib0014","doi-asserted-by":"crossref","unstructured":"Norgren, N., P. Sundstr\u00f6m, A. Svenningsson, L. Rosengren, T. Stigbrand, and M. Gunnarsson, 2004, Neurofilament and glial fibrillary acidic protein in multiple sclerosis: Neurology, vol. 63, p. 1586-90.","DOI":"10.1212\/01.WNL.0000142988.49341.D1"},{"key":"10.1016\/j.msard.2021.102810_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2014.12.027","article-title":"Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease","volume":"1600","author":"Petzold","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.msard.2021.102810_bib0016","doi-asserted-by":"crossref","unstructured":"Ponath, G., C. Park, and D. Pitt, 2018, The Role of Astrocytes in Multiple Sclerosis: Front Immunol, vol. 9, p. 217.","DOI":"10.3389\/fimmu.2018.00217"},{"key":"10.1016\/j.msard.2021.102810_bib0017","doi-asserted-by":"crossref","unstructured":"Saraste, M., S. Bezukladova, M. Matilainen, J. Tuisku, E. Rissanen, M. Sucksdorff, S. Laaksonen, A. Vuorimaa, J. Kuhle, D. Leppert, and L. Airas, 2021, High serum neurofilament associates with diffuse white matter damage in MS: Neurol Neuroimmunol Neuroinflamm, vol. 8.","DOI":"10.1212\/NXI.0000000000000926"},{"key":"10.1016\/j.msard.2021.102810_bib0018","doi-asserted-by":"crossref","unstructured":"Sbardella, E., F. Tona, N. Petsas, and P. Pantano, 2013, DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications: Mult Scler Int, vol. 2013, p. 671730.","DOI":"10.1155\/2013\/671730"},{"key":"10.1016\/j.msard.2021.102810_bib0019","doi-asserted-by":"crossref","unstructured":"Varhaug, K. N., C. Barro, K. Bj\u00f8rnevik, K. M. Myhr, \u00d8. Torkildsen, S. Wergeland, L. A. Bindoff, J. Kuhle, and C. Vedeler, 2018, Neurofilament light chain predicts disease activity in relapsing-remitting MS: Neurol Neuroimmunol Neuroinflamm, vol. 5, p. e422.","DOI":"10.1212\/NXI.0000000000000422"},{"key":"10.1016\/j.msard.2021.102810_bib0020","doi-asserted-by":"crossref","unstructured":"Varhaug, K. N., \u00d8. Torkildsen, K. M. Myhr, and C. A. Vedeler, 2019, Neurofilament Light Chain as a Biomarker in Multiple Sclerosis: Front Neurol, vol. 10, p. 338.","DOI":"10.3389\/fneur.2019.00338"},{"key":"10.1016\/j.msard.2021.102810_bib0021","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Y. Nakamura, Z. Michalak, N. Isobe, C. Barro, D. Leppert, T. Matsushita, F. Hayashi, R. Yamasaki, J. Kuhle, and J. I. Kira, 2019, Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD: Neurology, vol. 93, p. e1299-e1311.","DOI":"10.1212\/WNL.0000000000008160"},{"key":"10.1016\/j.msard.2021.102810_bib0022","doi-asserted-by":"crossref","unstructured":"Yang, Z., and K. K. Wang, 2015, Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker: Trends Neurosci, vol. 38, p. 364-74.","DOI":"10.1016\/j.tins.2015.04.003"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:56:04Z","timestamp":1761900964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":21,"alternative-id":["S2211034821000766"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102810","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102810"}}